Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2021, Vol. 48 Issue (2): 402-409    DOI: 10.31083/j.ceog.2021.02.2284
Original Research Previous articles | Next articles
Time interval between hCG administration and oocyte pick up: analysis of oocyte maturation, embryonic morphology, morphokinetics, and IVF outcome
Sivan Skvirsky1, *(), Idit Blais1, Shirly Lahav-Baratz1, Mara Koifman1, Zofnat Wiener-Megnazi1, Martha Dirnfeld1
1Department of Obstetrics and Gynecology, Division Reproductive Endocrinology-IVF Carmel Medical Center, Bruce and Ruth Rappaport Faculty of Medicine, 3100000 Haifa, Israel
Download:  PDF(590KB)  ( 152 ) Full text   ( 14 )
Export:  BibTeX | EndNote (RIS)      
Objective: To investigate associations of the time interval between hCG administration and oocyte pick up with oocyte maturation, embryonic morphology, morphokinetics, and IVF outcome, in different age groups. Design: A retrospective cohort study. Setting: An academic medical center. Patients: Women who underwent IVF and ICSI cycles in which all oocytes were incubated in a time lapse microscopy system (EmbryoScope). Cycles were stratified by age and time from hCG exposure. Interventions: None. Main Outcome Measures: Of 2185 IVF/ICSI OPU cycles, 820 cycles were included in the analysis. Final analysis was made on 796 cycles (4930 oocytes). Oocyte number and their maturity, fertilization rates, and embryo quality defined by morphology and morphokinetics, clinical pregnancy, and live birth rates. Results: The median hCG-oocyte pick up (OPU) interval was 34.45 hours. Among women over age 36 years, longer intervals were associated with both a higher fraction of mature oocytes (P < 0.008) and better morphology grading of embryos (P < 0.01). At all ages and all intervals, those with cleavage time, t2 ≤ 27 hours achieved a statistically significant higher clinical pregnancy rate. No differences were found in morphokinetics (t2) between different hCG-OPU intervals for any of the age groups. Conclusions: Extending hCG to OPU interval may be beneficial for patients aged > 36 years, as more mature eggs and better embryo morphology were achieved. In older women with fewer oocytes retrieved, even a small extra number of mature oocytes may prove crucial for treatment outcome and improve success rates. A prospective, randomized study is warranted to determine whether optimal hGC-retrieval time interval merits revision/adjustment for older women.
Key words:  Oocyte pick up      hCG interval      Mature oocytes      Embryo morphology      Morphokinetics     
Submitted:  05 September 2020      Revised:  01 December 2020      Accepted:  04 December 2020      Published:  15 April 2021     
*Corresponding Author(s):  Sivan Skvirsky     E-mail:

Cite this article: 

Sivan Skvirsky, Idit Blais, Shirly Lahav-Baratz, Mara Koifman, Zofnat Wiener-Megnazi, Martha Dirnfeld. Time interval between hCG administration and oocyte pick up: analysis of oocyte maturation, embryonic morphology, morphokinetics, and IVF outcome. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 402-409.

URL:     OR

No related articles found!
[1] Eli M. Roth, Michael H. Davidson. PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety[J]. Reviews in Cardiovascular Medicine, 2018, 19(S1): 31 -46 .
[2] Sandeep K. Krishnan, Norman E. Lepor. Acute and Chronic Cardiovascular Effects of Hyperkalemia: New Insights Into Prevention and Clinical Management[J]. Reviews in Cardiovascular Medicine, 2016, 17(S1): 9 -21 .
[3] Peter Shalit. Management of Dyslipidemia in Patients With Human Immunodeficiency Virus[J]. Reviews in Cardiovascular Medicine, 2014, 15(S1): 38 -46 .
[4] Sophie Mavrogeni, Fabrizio Cantini, Gerald M. Pohost. Systemic Vasculitis: An Underestimated Cause of Heart Failure—Assessment by Cardiovascular Magnetic Resonance[J]. Reviews in Cardiovascular Medicine, 2013, 14(1): 49 -55 .
[5] Prabhjot Singh Nijjar, Anoop Parameswaran, Aman M. Amanullah. Evaluation of Anomalous Aortic Origins of the Coronaries by 64-Slice Cardiac Computed Tomography[J]. Reviews in Cardiovascular Medicine, 2007, 8(3): 175 -181 .
[6] Jeffrey W. Moses, Stephane Carlier, Issam Moussa. Lesion Preparation Prior to Stenting[J]. Reviews in Cardiovascular Medicine, 2004, 5(S2): 16 -21 .
[7] Dean J. Kereiakes. Coronary Small-Vessel Stenting in the Era of Drug Elution[J]. Reviews in Cardiovascular Medicine, 2004, 5(S2): 34 -45 .
[8] Michael A. Weber. The Effects on Dementia of Long-Term Treatment of Hypertension[J]. Reviews in Cardiovascular Medicine, 2003, 4(3): 197 -198 .
[9] M. Pakiž, L. Lukman, N. Kozar. Patients' and physicians' expectations differ significantly during the follow-up period after completion of primary treatment of gynecological or breast cancer[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 781 -786 .
[10] T. Tomimatsu, S. Mabuchi, T. Tsuboyama, Y. Hori, S. Sekine, T. Kimura. Malignant transformation of uterine leiomyoma: suggested by clinical, imaging, histological, and genetic findings[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 879 -882 .